In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies.
Millership
J J
JJ
Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, USA.
Didier
E S
ES
Okhuysen
P C
PC
Maddry
J A
JA
Kwong
C D
CD
Chen
X
X
Snowden
K F
KF
D000626:Aminopeptidases / Q000037:antagonists & inhibitors*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003510:Cyclohexanes; D004195:Disease Models, Animal; D009670:Encephalitozoon cuniculi / Q000187:drug effects* / Q000254:growth & development; D016890:Encephalitozoonosis / Q000188:drug therapy* / Q000401:mortality* / Q000469:parasitology; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D005260:Female; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008819:Mice, Nude; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D021261:Parasitic Sensitivity Tests / Q000379:methods; D010455:Peptides; D012717:Sesquiterpenes / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003510:Cyclohexanes; D004791:Enzyme Inhibitors; D005231:Fatty Acids, Unsaturated; D010455:Peptides; D012717:Sesquiterpenes; C114434:nitrobestatin; C016977:amastatin; C026211:fumagillin; D000626:Aminopeptidases; D007930:Leucine; C012211:ubenimex; D000077609:O-(Chloroacetylcarbamoyl)fumagillol